Equashield’s State-of-the-Art Manufacturing Complex Fulfilling Customer Orders at Record Pace

Equashield, a leading provider of closed system transfer devices (CSTDs) for hazardous drugs, announced that its state-of-the-art, automated manufacturing facility is offering the company the ability to fulfill large quantity customer orders on-time, effectively neutralizing the global shortage and supply chain challenges that are plaguing delivery across industry.

“Our expectation of significant growth led us several years ago to develop a manufacturing facility that would be truly revolutionary in the CSTD space,” said Marino Kriheli, Co-founder of Equashield. “While we had no idea of the challenges the COVID era would bring, our insistence on building for the future has paid off dramatically over the past two years for nurses and pharmacists alike.”

Recommended AI News: HTC Partners with pixiv to Integrate VRoid’s Japanese Anime-Style Avatars into VIVERSE

Equashield implemented proprietary machine learning and artificial intelligence (AI) to its quality control and manufacturing lines in its 112,000 square foot manufacturing facility that includes a 20,000-square foot cleanroom space. Production is fully automated, from material entry to robot-managed packaging and palletizing, preserving the sterility of products while maintaining quality efficiency of manufacturing.

This facility, as well as a strong distribution arm in New York, now enables the company to build months of inventory to support increasing market demands with impeccable quality assurance and quick supply fulfillment worldwide.

Recommended AI News: Resecurity(R) Expands VAPT Capabilities with Acquisition of Cybit Sec in UAE

“Our world-class facility efficiently meets growing market demands and fu hazardous drug compounding and administration solutions,” said Jason Dutcher, Equashield LLC Strategic Sales Manager. “We pride ourselves on the ability to deliver safe exposure prevention to those who work with and around hazardous drugs.”

The Equashield CSTD provides unparalleled safety and ease of use for healthcare workers handling hazardous drugs. Key features include an integrated pressure equalization system within the sealed syringe barrel, a dry disconnection mechanism to prevent leaks, and Equashield’s proprietary closed syringe back and metal plunger rod to mitigate contamination and escape of hazardous drugs from the syringe back and plunger. Equashield’s CSTD portfolio includes a wide range of sealed-back syringes and adaptors that can accommodate any drug vial, along with a selection of connectors and tubing sets compatible with all IV infusion bags.

Recommended AI News: Oracle Automates the Tasks Sellers Despise with Next Generation CRM

[To share your insights with us, please write to sghosh@martechseries.com]